United States · FDA National Drug Code directory
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 35573-469_01fe666a-d04e-4dce-af71-8db45bbde653
- Product NDC
- 35573-469
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
- Labeler
- Burel Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191216 / 20280229
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 7.5 mg/1
- DEXTROAMPHETAMINE SULFATE — 7.5 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 7.5 mg/1
- AMPHETAMINE SULFATE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (35573-469-02) · 35573-469-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →